EUVIMEDSkopri EUVIMED
Crossref

Megalin‐related mechanism of hemolysis‐induced acute kidney injury and the therapeutic strategy

Sawako Goto iD, Michihiro Hosojima iD, Hideyuki Kabasawa iD, Kaho Arai, Kazuya Takemoto iD, Hiroyuki Aoki, Koichi Komochi iD, Ryota Kobayashi iD, Nanako Sugita, Taeko Endo, Ryohei Kaseda iD, Yutaka Yoshida and 3 more

The Journal of Pathology · 2024

DOI: 10.1002/path.6284 ↗

At a glance

Journal article in The Journal of Pathology, 2024. Written by Sawako Goto and 14 co-authors. Institution: Department of Applied Molecular Medicine, Kidney Research Center, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan. Major MEDLINE topics: Low Density Lipoprotein Receptor-Related Protein-2, Acute Kidney Injury, Hemolysis, Mice, Knockout. Cited 11 times so far (Crossref); 66 references. Funded by: Japan Agency for Medical Research and Development.

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Hemolysis‐induced acute kidney injury (AKI) is attributed to heme‐mediated proximal tubule epithelial cell (PTEC) injury and tubular cast formation due to intratubular protein condensation. Megalin is a multiligand endocytic receptor for proteins, peptides, and drugs in PTECs and mediates the uptake of free hemoglobin and the heme‐scavenging protein α 1 ‐microglobulin. However, understanding of how megalin is involved in the development of hemolysis‐induced AKI remains elusive. Here, we investigated the megalin‐related pathogenesis of hemolysis‐induced AKI and a therapeutic strategy using cilastatin, a megalin blocker. A phenylhydrazine‐induced hemolysis model developed in kidney‐specific mosaic megalin knockout (MegKO) mice confirmed megalin‐dependent PTEC injury revealed by the co‐expression of kidney injury molecule‐1 (KIM‐1). In the hemolysis model in kidney‐specific conditional MegKO mice, the uptake of hemoglobin and α 1 ‐microglobulin as well as KIM‐1 expression in PTECs was suppressed, but tubular cast formation was augmented, likely due to the nonselective inhibition of protein reabsorption in PTECs. Quartz crystal microbalance analysis revealed that cilastatin suppressed the binding of megalin with hemoglobin and α 1 ‐microglobulin. Cilastatin also inhibited the specific uptake of fluorescent hemoglobin by megalin‐expressing rat yolk sac tumor‐derived L2 cells. In a mouse model of hemolysis‐induced AKI, repeated cilastatin administration suppressed PTEC injury by inhibiting the uptake of hemoglobin and α 1 ‐microglobulin and also prevented cast formation. Hemopexin, another heme‐scavenging protein, was also found to be a novel ligand of megalin, and its binding to megalin and uptake by PTECs in the hemolysis model were suppressed by cilastatin. Mass spectrometry‐based semiquantitative analysis of urinary proteins in cilastatin‐treated C57BL/6J mice indicated that cilastatin suppressed the reabsorption of a limited number of megalin ligands in PTECs, including α 1 ‐microglobulin and hemopexin. Collectively, cilastatin‐mediated selective megalin blockade is an effective therapeutic strategy to prevent both heme‐mediated PTEC injury and cast formation in hemolysis‐induced AKI. © 2024 The Pathological Society of Great Britain and Ireland.

Subjects

MeSH terms (MEDLINE)

Low Density Lipoprotein Receptor-Related Protein-2Acute Kidney InjuryHemolysisMice, KnockoutKidney Tubules, ProximalAnimalsHemoglobinsMiceCilastatinDisease Models, AnimalPhenylhydrazinesMice, Inbred C57BLMaleHepatitis A Virus Cellular Receptor 1Alpha-GlobulinsHumans

Author keywords

acute kidney injurycilastatinhemoglobinhemolysismegalinnephrotoxicityproximal tubulerhabdomyolysis

Substances

Low Density Lipoprotein Receptor-Related Protein-2Lrp2 protein, mouseHemoglobinsCilastatinPhenylhydrazinesphenylhydrazineHavcr1 protein, mouseHepatitis A Virus Cellular Receptor 1Alpha-Globulinsalpha-1-microglobulin

Authors and institutions

  • Department of Applied Molecular Medicine, Kidney Research Center, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.
  • Department of Clinical Nutrition Science, Kidney Research Center, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.
  • Division of Clinical Nephrology and Rheumatology, Kidney Research Center, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.
  • Department of Bacteriology, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.
  • Vaccine & Diagnostic R&D Department, Denka Co., Ltd., Gosen, Japan.

ORCID profiles: Sawako Goto, Michihiro Hosojima, Hideyuki Kabasawa, Kazuya Takemoto, Koichi Komochi, Ryota Kobayashi, Ryohei Kaseda, Ichiei Narita, Akihiko Saito

Funding

  • Japan Agency for Medical Research and Development

Cite

APA

Goto, S., Hosojima, M., Kabasawa, H., Arai, K., Takemoto, K., Aoki, H., Komochi, K., Kobayashi, R., Sugita, N., Endo, T., Kaseda, R., Yoshida, Y., Narita, I., Hirayama, Y., & Saito, A. (2024). Megalin‐related mechanism of hemolysis‐induced acute kidney injury and the therapeutic strategy. The Journal of Pathology. https://doi.org/10.1002/path.6284

Vancouver

Goto S, Hosojima M, Kabasawa H, Arai K, Takemoto K, Aoki H, et al. Megalin‐related mechanism of hemolysis‐induced acute kidney injury and the therapeutic strategy. The Journal of Pathology. 2024. doi:10.1002/path.6284

BibTeX
@article{Goto2024,
  author = {Goto, Sawako and Hosojima, Michihiro and Kabasawa, Hideyuki and Arai, Kaho and Takemoto, Kazuya and Aoki, Hiroyuki and Komochi, Koichi and Kobayashi, Ryota and Sugita, Nanako and Endo, Taeko and Kaseda, Ryohei and Yoshida, Yutaka and Narita, Ichiei and Hirayama, Yoshiaki and Saito, Akihiko},
  title = {Megalin‐related mechanism of hemolysis‐induced acute kidney injury and the therapeutic strategy},
  journal = {The Journal of Pathology},
  year = {2024},
  doi = {10.1002/path.6284}
}
Start for free →